NCT03951103 - rFVIIIFc (Elocta®) ITI Chart Review in Patients With Haemophilia A | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

November 7, 2018

Primary Completion Date

September 30, 2022

Study Completion Date

September 30, 2022

Conditions

Hemophilia A With Inhibitor

Interventions

OTHER

rFVIIIFc

Drug according to prescription

Trial Locations (18)

Swedish Orphan Biovitrum Research Site, Riyadh

Swedish Orphan Biovitrum Research Site (a), Riyadh

Swedish Orphan Biovitrum Research Site (p), Riyadh

Swedish Orphan Biovitrum Research Site, Paris

Swedish Orphan Biovitrum Research Site, Rennes

Swedish Orphan Biovitrum Research Site, Tours

Swedish Orphan Biovitrum Research Site, Frankfurt

Swedish Orphan Biovitrum Research Site, Friedrichshain

Swedish Orphan Biovitrum Research Site, Hanover

Swedish Orphan Biovitrum Research Site, Mitte

Swedish Orphan Biovitrum Research Site, Dublin

Swedish Orphan Biovitrum Research Site, Catania

Swedish Orphan Biovitrum Research Site, Catanzaro

Swedish Orphan Biovitrum Research Site, Genova

Swedish Orphan Biovitrum Research Site, Napoli

Swedish Orphan Biovitrum Research Site, Kuwait City

Swedish Orphan Biovitrum Research Site, Oslo

Swedish Orphan Biovitrum Research Site, Bern